http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104940169-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-62 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4439 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-04 |
| filingDate | 2015-06-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2017-10-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2017-10-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-104940169-B |
| titleOfInvention | A kind of R-lansoprazole spansule and preparation method thereof |
| abstract | The invention belongs to technical field of medicine, it is intended to improve the bioavilability of R-lansoprazole in vivo.This product hardly discharges in hydrochloric acid in gastric juice, and reaching enteral can just be disintegrated, and make active component dissolution, so as to avoid destruction of the R-lansoprazole in hydrochloric acid in gastric juice.This product belongs to containing 2 kinds of different types of enteric-coated micro-pills, so as to reach the dual controlled release of 2 drug releases（DDR）.The present invention is during Utech S100 aqueous dispersions are prepared, by adding different amounts of alkaline matter, neutralizes the carboxyl of different molal quantitys in polymer, and control enteric material dissolves under different pH value, discharged twice so as to reach；It is coated using aqueous dispersion, effectively prevent ethanol residual. |
| priorityDate | 2015-06-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 56.